Simple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapy-Reference-Cited by-同舟云学术

Simple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapy

Published:2016 Issue:5 Volume:45 Page:1432-1456
ISSN:0306-0012
Container-title:Chemical Society Reviews
language:en
Short-container-title:Chem. Soc. Rev.

Author:

Liu Zhibo¹²³⁴⁵,Chen Xiaoyuan¹²³⁴⁵

Affiliation:

1. Laboratory of Molecular Imaging and Nanomedicine

2. National Institute of Biomedical Imaging and Bioengineering

3. National Institutes of Health

4. Bethesda

5. USA

Abstract

Albumin is the most abundant circulating protein in plasma and has recently emerged as a versatile protein carrier for drug targeting and for improving the pharmacokinetic profile of peptide or protein based drugs.

Funder

National Institutes of Health

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2016/CS/C5CS00158G

Reference211 articles.

1. Albumin Microspheres as Vehicles for Achieving Specificity in Drug Delivery

2. Therapeutic Nanoparticles for Drug Delivery in Cancer

3. Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles

4. Albumin affinity tags increase peptide half-life in vivo

Cited by 346 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conversion of albumin into a BODIPY-like photosensitizer by a flick reaction, tumor accumulation and photodynamic therapy;Biomaterials;2025-02

2. Construction of a human serum albumin site II-targeting supramolecular fluorescent probe for cell imaging and drug delivery;Journal of Molecular Structure;2024-09

3. Hazards of antiviral contamination in water: Dissemination, fate, risk and their impact on fish;Journal of Hazardous Materials;2024-09

4. Maximizing arsenic trioxide's anticancer potential: Targeted nanocarriers for solid tumor therapy;Colloids and Surfaces B: Biointerfaces;2024-09

5. Revolutionizing Alzheimer's treatment: Harnessing human serum albumin for targeted drug delivery and therapy advancements;Ageing Research Reviews;2024-08